Physician Profiles

Education

Fellowship in Endocrinology, George Washington University Medical Center, Washington, DC, 1982

Residency, Internal Medicine, Long Island Jewish Hillside Medical Center, 1978 - 1980

Internship, Long Island Jewish - Hillside Medical Center, 1977 - 1978

M.D., Thomas Jefferson Medical School, Philadelphia, Pennsylvania, 1973 - 1977

Bachelor of Science, Magna Cum Laude, University of Pennsylvania, Philadelphia, PA, 1969 - 1973

Board Certification

AACE/ISCD Bone Density Measurement Post Graduate Certification Course

The International Society of Clinical Densitometry

American Board of Endocrinology and Metabolism

American Board of Internal Medicine

National Board of Medical Examiners

Academic Appointments

Fellow of American College Clinical Endocrinology, 1995

Clinical Instructor, University of Texas Health Science Center at San Antonio, Department of Medicine, Division of Endocrinology, 1983 - present

Associate, Department of Medicine, George Washington University Medical Center, 1980 - 1982

Professional Memberships

American Medical Informatics Association, 1998 to present

American Society of Internal Medicine, 1996 – present

American Association of Clinical Endocrinologists (AACE), 1993 – present

The Endocrine Society, 1992 – present

Texas Medical Association, 1984 – present

Bexar County Medical Society, 1983 – present

American Diabetes Association, 1981 – present

American Medical Association, 1978 – present

Staff Physician

CHRISTUS Santa Rosa Medical Center

2827 Babcock Road

San Antonio, Texas 78229

Methodist Specialty & Transplant Hospital

(Formerly San Antonio Community Hospital)

8026 Floyd Curl Drive

San Antonio, Texas 78229

Southwest Texas Methodist Hospital

7700 Floyd Curl Drive

San Antonio, Texas 78229

St. Luke’s Baptist Hospital

7930 Floyd Curl Drive

San Antonio, Texas 78229

Methodist Children’s Hospital

(Formerly Methodist Women’s & Children’s Hospital)

7700 Floyd Curl Drive

San Antonio, Texas  78229

Professional Activities

Co–Director, Sixth South Texas Clinical Diabetes Symposium, San Antonio, Texas, 1988

Co–Director, 5K Diabetes Run (Humanathon), 1984 - 1987

Co–Director, Fifth South Texas Clinical Diabetes Symposium, San Antonio, Texas, 1987

Co-Director, Fourth Bi – Annual South Texas Clinical Diabetes Symposium, San Antonio, Texas, 1986

Co-Director, Third Bi – Annual South Texas Clinical Diabetes Symposium, San Antonio, Texas, 1985

Director, Eating Disorder Unit, Methodist Specialty & Transplant Hospital (formerly San Antonio Community Hospital), 1984 - 1985

Faculty Member, University of Texas Health Center at San Antonio, First Annual Update on Medicine, Laredo, Texas, 1985

Co–Director Second Bi – Annual South Texas Clinical Diabetes Symposium, San Antonio, Texas, 1983

Co–Director, Diabetes Center of Excellence, Methodist Specialty & Transplant Hospital (formerly San Antonio Community Hospital), 1983 - present

Co-Director, Diabetes and Glandular Disease Clinic, San Antonio, Texas, 1982 - present

Coordinator of Young Adult Week at Camp Glyndon, Camp for Children with Diabetes

Mellitus, 1982

Advisory Board, Diabetes Center of Excellence, Methodist Specialty & Transplant Hospital (formerly San Antonio Community Hospital), 1982 - present

Member, MD Team at Camp Glyndon, Camp for Children with Diabetes Mellitus, 1980 - 1981

Chairman, Department of Medicine, Methodist Specialty & Transplant Hospital (formerly San Antonio Community Hospital), San Antonio, Texas

Lectures

Microsoft Health Users Group – Windows on Health Care, October 12, 1998

Speakers’ Program, Nursing Education Satellite Network - Diabetes:  DCCT, Video Conference and videotapes, April, 1995

Speakers’ Program, Parke-Davis, 1988 -  present

Speakers’ Program, Bristol-Myers Squibb, 1988 - present

Speakers’ Program, Merck & Co., Inc., 1988 - present

Speakers’ Program, Pfizer, Inc., 1984 - present

Speakers’ Program, Eli Lilly, 1983 - present

Town Hall Meetings (Diabetes Mellitus Updates), Midland, Texas, 1983

Town Hall Meetings (Diabetes Mellitus Updates), San Antonio, Texas, 1983

Federal Aviation Medical Seminar, 1983 - 1984

Pharmacy Series, San Antonio, Texas, 1984

Pharmacy Series, H.E.B. Pharmacists of Texas, 1984

Eli Lilly Postgraduate Lecture Series, San Antonio Pharmacists, 1983

Midland Memorial, Midland, Texas, 1983

Odessa Medical Center, Odessa, Texas, 1983

Speakers’ Program, Diabetes Mellitus, Type I and Type II, New Insulin, Insulin Pump,

Second Generation Oral Hypoglycemic Agents, Victoria Hospital, Victoria, Texas, 1983

St. Agnes Hospital, Fond du lac, Wisconsin, 1983

Speakers’ Program, Diabetes Mellitus, Type I and Type II, New Insulin, Insulin Pump, Second Generation Oral Hypoglycemic Agents, Frio Hospital, Frio, Texas, 1982

Speakers’ Program, Diabetes Mellitus, Type I and Type II, New Insulin, Insulin Pump, Second

Generation Oral Hypoglycemic Agents, Education Service Center, Region 20, 1982

Teleconference Network of Texas

Diabetes and Diet, 1989

Diabetes - New Pharmacology, 1986

Insulin and Insulin Delivery, 1986

Osteoporosis, 1986

Management of Diabetes Mellitus, April 1985

Treatment Aspects of Severe Anorexia and Bulimia, November 1984

Publications

Diabetes Care Documentation & Coding For Clinicians.  Jerome S. Fischer, M.D. ă2002 by the American Diabetes Association, Inc.  Professional Books.  Library of Congress Cataloging-in-Publication Data.

“Sugar-Free Zinc Gluconate Glycine Lozenges (Cold Eeze®) Do Not Adversely Affect Glucose Control in Patients with Type 1 or Type 2 Diabetes Mellitus”.  Sherwyn L. Schwartz, M.D.; Jerome S. Fischer, M.D.; Mark S. Kipnes, M.D.  American Journal Of Therapeutics, 1075-2765 © 2001 Lippincott Williams & Wilkins pp. 006-0611.

“Effects of Short-Term Insulin Therapy Upon Therapeutic Response to Glipizide.” Schwartz, Sherwyn L.; Fischer, Jerome S. and Kipnes, Mark S., MDs and Boyle, Mary, R.N..  The American Journal of Medicine, (Supplement 3A), September 18, 1987, pp. 22-30.

“Perioperative Management of the Patient with Diabetes Mellitus Undergoing Outpatient or Elective Surgery”. Fetchick, Dianne A. and Fischer, Jerome S., MDs.  Clinics in Podiatric Medicine and Surgery, 4 (Number 2), April 1987, pp. 432-443.

Guidelines to Diabetes Management for the Primary Care Physician, 1985, Editorial Board, Professional Education Committee, Texas Affiliate, Inc., American Diabetes Association.

Abstracts

Plasma Glucose and Insulin Response to Isocaloric Amounts of Enteral Formulas in Persons with Type 2 Diabetes Mellitus.  S.L. Schwartz, M.D.; J. Fischer, M.D.; M. Kipnes, M.D. and L. Kelly, R.N.  Diabetes and Glandular Disease Research Center, San Antonio, TX.  Currently used by Norvartis Nutritional, in their brochures and on their Website.  January, 2003. 

Long Term Effect of Glitazones in Clinical Practice.  WILLIAM F. TRIGOSO, JACOB VADAKEKALAM, SHERWYN SCHWARTZ, JEROME FISCHER, MARK KIPNES, AMNA SALHIN, DAINA DREIMANE, LITZA LOZA.  San Antonio, TX.  Diabetes, A Journal of The American Diabetes Association, Abstract Book, 62^nd Scientific Sessions, June 14 – 18, 2002, Volume 51, Supplement 2.

“COMMUNITY SCREENING FOR DIABETES:  SHOULD DEMOGRAPHICS BE A FACTOR”?    Mark S. Kipnes, Sherwyn L. Schwartz, Jerome S. Fischer, William F. Trigoso, Amna A. Salhin, Jacob Vadakekalam, Daina Dreimane, William D. Linn.  American Association of Clinical Endocrinologists 10^th Annual Meeting & Clinical Congress.  May 2-6, 2001.  San Antonio, Texas.

A Comparison of the Pharmacodynamic Effects of Inhaled Insulin versus Subcutaneous Insulin in Type 1 Diabetic Patients.  Mark Kipnes, Babatunde Otulana, Per Clauson, Jerome Fischer, Stephen J. Farr, Vibeke Hatorp, Sherwyn Schwartz, Hayward, CA.  Diabetes, A Journal of the American Diabetes Association, Abstract Book, 59^th Scientific Sessions, May 1999, Volume 48, Supplement I, pp. A95.

Abstract #456, Diabetes, A Journal of the American Diabetes Association, 43^rd Scientific Sessions, May 1983, Volume 32, Supplement 1, pp. 118A.

Poster Presentations

Impact of Achieved Systolic Blood Pressure On Renal Function In Type 2 Diabetic Nephropathy.  Marc A. Pohl, MD¹; Samuel Blumenthal, MD²; Lawrence G. Hunsicker, MD³ and The Collaborative Study Group⁴. ¹Cleveland Clinic Fdn., Cleveland Ohio; ²Veterans Administration, Milwaukee, Wisconsin; ³University of Iowa Hospitals and Clinics, Iowa City, Iowa and ⁴Rush Medical College, Chicago, Illinois.  Presented at the ASN Meeting, November 2002. 

Impact Of Angiotensin Receptor Blockade With Irbesartan On Renal Function At Different Systolic Blood Pressure (SBP) Levels In Type 2 Diabetic Nephropathy.  Marc A. Pohl, MD¹; Daniel J. Cordonnier, MD²; Samuel Spitalewitz, MD³ and The Collaborative Study Group⁴.  ¹Cleveland Clinic Foundation, Cleveland Ohio; ²University of Grenoble, Grenoble, France; ³Brooklyn Hospital Medical Center, Brooklyn, NY and ⁴Rush Medical College, Chicago, Illinois.  Presented at the ASN Meeting, November 2002. 

The Severity Of Orthostatic Hypotension Is A Risk Factor In The Progression Of Type 2 Diabetic Nephropathy.  Matthew R. Weir, MD and Lawrence G. Hunsicker, MD, for The Collaborative Study Group, Chicago Illinois.  Presented at the ASN Meeting, November 2002. 

The Presence Of Retinopathy Is Associated With Poor Renal And Cardiovascular Outcomes In Type 2 Diabetic Nephropathy.  Roger Rodby, MD¹; Richard Gilbert, MD², for The Collaborative Study Group, ¹Chicago, Illinois USA.  ²Victoria, Australia.  Presented at the ASN Meeting, November 2002. 

Predictors Of The Progression Of Renal Insufficiency In Patients With Type 2 Diabetes And Overt Diabetic Nephropathy.  John P. Middleton, Julia Lewis, for The Collaborative Study Group University of Texas Southwestern, Dallas, Texas; Vanderbilt University, Nashville, Tennessee.  Presented at the ASN Meeting, November 2002. 

Cardiovascular Outcomes In The Irbesartan Diabetic Nephropathy Trial (IDNT) Of Patients With Type 2 Diabetes And Overt Nephropathy.  Tomas Berl, MD¹ for The Collaborative Study Group².  ¹Division of Renal Diseases and Hypertension, University of Colorado², Denver, Colorado Department of Medicine, Rush Medical Center, Chicago, Illinois.  Presented at the ASN Meeting, November 2002. 

Impact of Use of Insulin, Glargine, on Hbg A1c and BMI in a Specialty (Endocrine) Practice Population.  JEROME S. FISCHER, RIAD G. DIRANI, SHERWYN L. SCHWARTZ, MARK S. KIPNES, FERNANDO W. TRIGOSO, AMNA A. SALHIN, JACOB VADAKEKALAM, DAINA DREIMANE, LITZA LOZA.  San Antonio, TX; Bridgewater, NJ.  Diabetes, A Journal of The American Diabetes Association, Abstract Book, 62^nd Scientific Sessions, June 14 – 18, 2002, Volume 51, Supplement 2.

Physiologic Differences Between Volar and Dorsal Capillary Forearm Glucose Concentrations and Finger Stick Glucose Concentrations in Diabetics.  STEPHEN L. MONFRE, KEVIN H. HAZEN, JEROME S. FISCHER, MATTHEW WELCH, LINDA HOCKERSMITH, RYAN J. GUTTRIDGE, TIMOTHY L. RUCHTI.  Chandler, AZ; San Antonio, TX.  Diabetes, A Journal of The American Diabetes Association, Abstract Book, 62^nd Scientific Sessions, June 14 – 18, 2002, Volume 51, Supplement 2.

Influence of HbA1c on the Efficacy and Safety of Vardenafil for the Treatment of Erectile Dysfunction in Men with Diabetes. IRWIN GOLDSTEIN, JEROME FISCHER, TERRY TAYLOR, MARC THIBONNIER.  Boston, MA; San Antonio, TX; West Haven, CT.  Diabetes, A Journal of The American Diabetes Association, Abstract Book, 62^nd Scientific Sessions, June 14 – 18, 2002, Volume 51, Supplement 2.

Comparisons of Capillary Blood Glucose Concentrations from the Fingertips and the Volar Aspects of the Left and Right Forearm.  JEROME S. FISCHER, KEVIN H. HAZEN, MATTHEW WELCH, LINDA HOCKERSMITH, JENNIFER COATES.  San Antonio, TX; Chandler AZ.  Diabetes, A Journal of The American Diabetes Association, Abstract Book, 62^nd Scientific Sessions, June 14 – 18, 2002, Volume 51, Supplement 2.

Calibration Break-Through for Near-Infrared, Non-Invasive Blood Glucose Monitoring.  SATISH K. GARG, JEROME S. FISCHER, TIMOTHY L. RUCHTI, THOMAS B. BLANK, ALEX D. LORENZ, STEPHEN L. MONFRE.  Denver, CO; San Antonio, TX; Chandler, AZ.  Diabetes, A Journal of The American Diabetes Association, Abstract Book, 62^nd Scientific Sessions, June 14 – 18, 2002, Volume 51, Supplement 2.

“THE AVANDIA WORLDWIDE AWARENESS REGISTRY (AWAReŇ):  AN INTERNET-BASED PROGRAM FOR EVALUATION OF CLINICAL, HUMANISTIC AND ECONOMIC OUTCOMES OF PATIENTS WITH TYPE 2 DIABETES.”  Bakst A.W., Meletiche D.M., Arnold R., Pettit K., Harjono H., Najib M., Cobitz A., Schwartz S.  Kipnes M, Fischer J, GlaxoSmithKline, Collegeville PA, Pharmacon International, New York, N.Y. Poster presented at ISPOR meeting May, 2001.

“Effects of Troglitazone on HbA_1c and ALT Levels in Clinical Practice”.  Sherwyn L. Schwartz, M.D., Jerome S. Fischer, M.D., Mark S. Kipnes, M.D., San Antonio, TX.  For presentation at the President’s Poster Session and Reception, American Diabetes Association 59^th Scientific Sessions, June 20, 1999, San Diego, CA..

A Clinical Trial In Patients With Overt Type 2 Diabetic Nephropathy.  EJ Lewis; LG Hunsicker; WC Clarke for the Collaborative Study Group, Chicago IL and Iowa City, Iowa.  Presented at the ASN meeting November 2001.

Research

Clinical Trials Listing available upon request.

E-mail / Web Page Address

E-mail:             webmaster@dgdclinic.com

Web Page:      www.dgdclinic.com

[ Home ] [ Back ] [ Next ] [ Back to Physician Profiles ]

© 1979- 2007 DGD